Singapore markets close in 2 hours 6 minutes

Vertex Pharmaceuticals Incorporated (VRTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
495.91+4.34 (+0.88%)
At close: 04:00PM EDT
494.96 -0.95 (-0.19%)
After hours: 07:20PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 127.97B
Enterprise value 118.52B
Trailing P/E 32.18
Forward P/E 30.77
PEG ratio (5-yr expected) 0.67
Price/sales (ttm)12.69
Price/book (mrq)6.90
Enterprise value/revenue 11.64
Enterprise value/EBITDA 23.67

Trading information

Stock price history

Beta (5Y monthly) 0.39
52-week change 338.50%
S&P500 52-week change 321.83%
52-week high 3498.77
52-week low 3340.20
50-day moving average 3469.84
200-day moving average 3417.79

Share statistics

Avg vol (3-month) 31.18M
Avg vol (10-day) 31.08M
Shares outstanding 5258.05M
Implied shares outstanding 6258.05M
Float 8257.31M
% held by insiders 10.10%
% held by institutions 195.89%
Shares short (28 Jun 2024) 44.1M
Short ratio (28 Jun 2024) 42.99
Short % of float (28 Jun 2024) 41.59%
Short % of shares outstanding (28 Jun 2024) 41.59%
Shares short (prior month 31 May 2024) 44.35M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 324 Aug 2000

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024


Profit margin 39.46%
Operating margin (ttm)45.20%

Management effectiveness

Return on assets (ttm)12.82%
Return on equity (ttm)24.38%

Income statement

Revenue (ttm)10.18B
Revenue per share (ttm)39.49
Quarterly revenue growth (yoy)13.30%
Gross profit (ttm)N/A
Net income avi to common (ttm)4.02B
Diluted EPS (ttm)15.42
Quarterly earnings growth (yoy)57.10%

Balance sheet

Total cash (mrq)10.17B
Total cash per share (mrq)39.42
Total debt (mrq)721.3M
Total debt/equity (mrq)3.89%
Current ratio (mrq)3.50
Book value per share (mrq)71.80

Cash flow statement

Operating cash flow (ttm)3.94B
Levered free cash flow (ttm)3.31B